Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Langley

Showing results (51-60 of 333) with videos related to

Pageof 34
Sort By:
Pharmacy (Basel, Switzerland)|July 17, 2020
The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds in Health Technology AssessmentPaul C Langley
Journal of Medical Economics|July 28, 2012
The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costsPaul C Langley
Innovations in Pharmacy|January 11, 2023
Evidentiary Standards for Patient-Centered Core Impact (PC-CIS) Value ClaimsPaul C Langley
Journal of Medical Economics|November 10, 2015
Validation of modeled pharmacoeconomic claims in formulary submissionsPaul C Langley
Current Medical Research and Opinion|May 17, 2016
Na domhain shamhlaíochta: formulary submission guidelines in Ireland and the standards of normal sciencePaul C Langley
Current Medical Research and Opinion|March 10, 2004
Focusing pharmacoeconomic activities: reimbursement or the drug life cycle?Paul C Langley
Journal of Medical Economics|November 26, 2009
A cost-effectiveness analysis of sinecatechins in the treatment of external genital wartsPaul C Langley
Clinical Therapeutics|November 1, 1993
The role of pharmacoeconomic guidelines for formulary approval: the Australian experienceP C Langley
Pharmacoeconomics|June 6, 1996
Cost effectiveness and the allocation of therapies in a treating populationP C Langley
Pharmacoeconomics|November 11, 1999
Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilitiesP C Langley
Pageof 34

Showing results (51-60 of 333) with videos related to

Sort By:
Pageof 34
Pharmacy (Basel, Switzerland)|July 17, 2020
The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds in Health Technology AssessmentPaul C Langley
Journal of Medical Economics|July 28, 2012
The societal burden of pain in Germany: health-related quality-of-life, health status and direct medical costsPaul C Langley
Innovations in Pharmacy|January 11, 2023
Evidentiary Standards for Patient-Centered Core Impact (PC-CIS) Value ClaimsPaul C Langley
Journal of Medical Economics|November 10, 2015
Validation of modeled pharmacoeconomic claims in formulary submissionsPaul C Langley
Current Medical Research and Opinion|May 17, 2016
Na domhain shamhlaíochta: formulary submission guidelines in Ireland and the standards of normal sciencePaul C Langley
Current Medical Research and Opinion|March 10, 2004
Focusing pharmacoeconomic activities: reimbursement or the drug life cycle?Paul C Langley
Journal of Medical Economics|November 26, 2009
A cost-effectiveness analysis of sinecatechins in the treatment of external genital wartsPaul C Langley
Clinical Therapeutics|November 1, 1993
The role of pharmacoeconomic guidelines for formulary approval: the Australian experienceP C Langley
Pharmacoeconomics|June 6, 1996
Cost effectiveness and the allocation of therapies in a treating populationP C Langley
Pharmacoeconomics|November 11, 1999
Formulary submission guidelines for Blue Cross and Blue Shield of Colorado and Nevada. Structure, application and manufacturer responsibilitiesP C Langley
Pageof 34